Adagrasib

Introduction Dasatab 20 mg (Dasatinib) Tablet is a highly effective tyrosine kinase inhibitor designed for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) and acute lymphoblastic leukemia (Ph+ ALL). Manufactured by Eskayef Pharmaceuticals Ltd. and supplied globally by Onco Solution, Dasatab 20 mg (Dasatinib) Tablet targets BCR-ABL and SRC family kinases, offering a potent therapeutic option for patients resistant […]